Pierre Fabre Laboratories
Pierre Fabre Laboratories and Iktos announce oncology collaboration
January 21, 2026Research and Development Iktos, Oncology, Pierre Fabre Laboratories
Pierre Fabre Laboratories and Iktos have announced a new collaboration intended to discover and develop new small-molecule drug candidates for …
Pierre Fabre announces investments and partnerships in lung cancer research
March 27, 2025Research and Development Oncology, Pierre Fabre Laboratories, lung cancer treatment, oncology
Pierre Fabre Laboratories has announced investment and partnership plans to improve the lives of lung cancer patients with unmet needs. …
Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI  in combination with MEKTOVI  for the treatment of adult patients with advanced non-small cell lung cancer  NSCLC) with a BRAFV600E mutation
July 29, 2024Clinical Trial Services BRAF mutation, CHMP, EMA, Oncology, Pierre Fabre Laboratories, colorectal cancer, european studies, non-small cell lung cancer
Pierre Fabre Laboratories has announced a positive opinion from the European Medical Association’s (EMA) Committee for Medicinal Products Human use …
Latest content
Global coalition calls for stronger government action on COPD
September 18, 2026
Global health researchers call for more equitable partnerships
September 17, 2026
Liverpool launches £20m lab for infectious disease drug discovery
September 16, 2026
Circle Health Group expands into UK laboratory operations
September 15, 2026
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
September 14, 2026
